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Fetal oocyte attrition (FOA) is a conserved but poorly
understood process of elimination of more than two-
thirds of meiotic prophase I (MPI) oocytes before
birth. We now implicate retrotransposons LINE-1
(L1), activated during epigenetic reprogramming of
the embryonic germline, in FOA in mice. We show
that wild-type fetal oocytes possess differential
nuclear levels of L1ORF1p, an L1-encoded protein
essential for L1 ribonucleoprotein particle (L1RNP)
formation and L1 retrotransposition. We demon-
strate that experimental elevation of L1 expression
correlates with increased MPI defects, FOA, oocyte
aneuploidy, and embryonic lethality. Conversely,
reverse transcriptase (RT) inhibitor AZT has a pro-
found effect on the FOA dynamics and meiotic
recombination, and it implicates an RT-dependent
trigger in oocyte elimination in earlyMPI.We propose
that FOA serves to select oocytes with limited L1
activity that are therefore best suited for the next
generation.
INTRODUCTION
Fetal oocyte attrition (FOA) is the process of elimination of
80% of the initial pool of human oocytes by the time of birth
(Baker, 1963; Kurilo, 1981). This process is not unique to
humans and has been observed in primates and extensively
documented in several rodent species (Baker, 1966; Beaumont
and Mandl, 1962; Burgoyne and Baker, 1985; Ioannou, 1964;
McClellan et al., 2003). In addition, oocyte loss is observed in
invertebrates, suggesting a possibility of ancient evolutional
origin of FOA (Matova and Cooley, 2001). In mice, fetal oocyte
loss occurs continuously throughout the meiotic prophase I
(MPI) and appears to require, at least in part, apoptotic
mechanisms (Bergeron et al., 1998; Ene et al., 2013; Ghafari
et al., 2007; McClellan et al., 2003; Morita et al., 2000). How-
ever, despite the apparent evolutional conservation of FOA,
questions of the molecular basis and rationale (if any) for
oocyte purging remain open (Hartshorne et al., 2009). OverDevethe years, a few scenarios have been considered, but none
have been firmly ruled out or confirmed experimentally (Tilly,
2001). These include ‘‘death by neglect,’’ ‘‘death by defect,’’
and ‘‘death by self-sacrifice’’ that correspond to proposed roles
of growth factors, meiotic checkpoints, and cyst organization of
the embryonic oogenesis (Barlow et al., 1998; Lei and Spra-
dling, 2013; Morita et al., 1999, 2001; Pepling and Spradling,
2001).
Over the past decade, DNA methylation remodeling of the
embryonic germline has become recognized as an important
aspect of germ cell development and differentiation (Lees-Mur-
dock and Walsh, 2008; Popp et al., 2010; Seisenberger et al.,
2012). The erasure of repressive DNA methylation creates a
window of opportunity for expression of transposable elements
(TEs) whose intact and mutated copies constitute 40% of the
mouse genome (Bourc’his and Bestor, 2004; Hajkova et al.,
2002; Walsh et al., 1998; Waterston et al., 2002). At least two
mechanisms, DNA methylation and PIWI-interacting RNAs
(piRNAs), are required to efficiently silence TEs de novo (Aravin
and Bourc’his, 2008; Bourc’his and Bestor, 2004). Studies of
mouse mutants lacking piRNAs demonstrated the essential
role of these small RNAs in transcriptional and posttranscrip-
tional transposon control (Aravin et al., 2008; Kuramochi-Miya-
gawa et al., 2008). Interestingly, upregulation of transposons is
particularly detrimental to MPI male germ cells (Aravin et al.,
2009; Carmell et al., 2007; Ollinger et al., 2010; Shoji et al.,
2009; Soper et al., 2008). This observation is important
because the onset of DNA methylation reprogramming and
transposon derepression just precede sex determination of pri-
mordial germ cells, which is manifested as the cell-cycle arrest
of prospermatogonia and the meiotic entry of oocytes (Seisen-
berger et al., 2012; Western, 2009). Therefore, by analogy with
lethality of piRNA- or DNA methylation-deficient spermato-
cytes, massive elimination of fetal oocytes could be a product
of the concurrency of transposon derepression and meiotic
initiation (Figure 1A). Whereas none of the reported mouse
mutants lacking piRNA machinery have been described to
exhibit female infertility, a prior study linked extensive global
DNA demethylation in the Hells/LSH mutant with MPI defects
and derepression of IAP elements, which otherwise elude ex-
tensive DNA methylation reprogramming (De La Fuente et al.,
2006; Lane et al., 2003). In this work, we set out to examine
the impact of retrotransposons on viability and quality of fetal
oocytes in mice.lopmental Cell 29, 521–533, June 9, 2014 ª2014 Elsevier Inc. 521
Figure 1. L1 Expression in Meiotic Prophase I Fetal Oocytes
(A) Meiotic prophase I in oocytes coincides with epigenetic reprogramming of
the germ cell genome and activation of retrotransposon expression.
(B) Single and merged channels of single confocal sections of E18.5 WT ovary
showing L1ORF1p (green) expression in TRA98-positive (red) fetal oocytes
counterstained with DAPI (blue).
See also Figure S1.
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Mutation ofMael Increases L1 Expression and
Enhances Fetal Oocyte Attrition
We reasoned that expression of transposable elements through-
out MPI could contribute to FOA (Figure 1A). To test this
hypothesis, we first used immunofluorescence to assess fetal
oocyte expression of two classes of retrotransposons active in
the mouse genome—non-LTR retrotransposons L1 and endog-
enous retroviruses IAP (Goodier and Kazazian, 2008). Based on
immunostaining for L1ORF1p, an L1-encoded protein that is a
component of L1 ribonucleoprotein particles (L1RNPs) with an
essential role in L1 retrotransposition (Doucet et al., 2010; Mar-
tin, 2006; Martin et al., 2008), L1 elements were found to be
expressed in all MPI oocytes of the fetal ovary (Figure 1B). In
contrast, we did not detect IAP GAG protein expression until
later in oogenesis (Figure S1 available online). This is consistent
with a report of IAPs being resistant to epigenetic reprogram-
ming (Lane et al., 2003). Given these observations and persis-522 Developmental Cell 29, 521–533, June 9, 2014 ª2014 Elsevier Intence of L1 activity in the human genome (Beck et al., 2010;
Brouha et al., 2003; Kazazian, 2004), we focused our subsequent
studies on L1 elements.
To assess the effect of increased L1 expression on viability of
fetal oocytes, we first studied mice lacking themaelstrom homo-
log (Drosophila) (Mael) gene that encodes a protein with an
evolutionarily conserved role in transposon silencing (Aravin
et al., 2009; Lim and Kai, 2007; O’Donnell et al., 2008; Sienski
et al., 2012; Soper et al., 2008). Using anti-MAEL antibodies
(Soper et al., 2008), we detected MAEL expression in fetal
oocytes and in primordial and primary follicles (Figures 2A–2F).
Mael-null embryonic day 15.5 (E15.5) ovaries contained a 2.3-
and 2.4-fold excess of L1 mRNA and L1ORF1p, respectively,
above levels already present in the wild-type (WT; Figures 2G–
2I). RNA-Seq analysis of WT and Mael-null E15.5 ovaries re-
vealed abundant expression of L1 elements of active families
and their 2-fold increase in the Mael mutant (Figure S2A). We
also observed increased expression of genes associated with
cell death and transcripts from contaminating hematopoietic
cells but did not see altered expression of geneswith established
roles in germ cells or meiosis (Figure S2B, Table S1, and Exper-
imental Procedures).
To evaluate the effect of theMaelmutation on FOA, we quan-
tified oocytes in E15.5, E18.5, and postnatal day 2 (P2) WT and
Mael mutant ovaries. At E15.5, when all oocytes have entered
MPI, ovaries of both genotypes had comparable oocyte
numbers (Figure 3A; Tables S2A and S2B). However, of the initial
WT and Mael-null E15.5 populations, only 55% and 18% sur-
vived to E18.5, and 40% and 14% to P2, respectively (Figure 3A;
Tables S2A and S2B). Therefore, upregulation of L1 expression
in Mael-null fetal oocytes correlated with their reduced viability.
Differential Accumulation of L1ORF1p in Fetal Oocyte
Nuclei
We next wanted to understand how widespread derepression of
L1 expression in the female germline could lead to elimination of
not all but only a subpopulation of fetal oocytes. Because L1
must reach the oocyte genome to retrotranspose and cause
DNA damage during this process (Belgnaoui et al., 2006; Gasior
et al., 2006; Soper et al., 2008), we examined nuclear levels of
L1ORF1p, an RNA-binding chaperone protein and essential
component of L1RNPs (Martin, 2006; Martin et al., 2005,
2008), in fetal oocytes. Unexpectedly, we observed that oocytes
of the same age and genotype exhibited significant variation of
nuclear levels of L1ORF1p immunofluorescence (Figure 3B). To
further characterize this variation, we developed an approach
to determine relative mean nuclear (RMN) L1ORF1p levels in in-
dividual fetal oocytes (Figure 3C and Experimental Procedures).
Using this approach, we quantified nuclear L1ORF1p levels in
WT and Mael-null E15.5, E18.5, and P2 oocytes (Figure 3D;
Tables S2C and S2D). This analysis revealed broad ranges of
nuclear L1ORF1p accumulation even in the starting population
of WT and Mael-null E15.5 oocytes with maximum values of
6.62 and 7.92 RMN units, respectively. In surviving WT E18.5
oocytes (55% of the starting E15.5 population), L1ORF1p levels
peaked 8.7 RMN units compared to the maximum of 9.0 RMN
units in Mael-null oocytes that survived to E18.5 (18% of
the starting E15.5 population). Despite comparable ranges of
L1ORF1p nuclear accumulation between the two genotypes,c.
Figure 2. MAEL Is Required for L1 Regula-
tion in Fetal Ovaries
(A) Section of E16.5 Mael mutant ovary section
probed with MAEL antibody.
(B) Cytoplasmic MAEL (green) localization in WT
E15.5 oocytes. SYCP2 (red) marks chromosome
axes.
(C–F) WT ovaries of indicated developmental
stages and ages probed with MAEL antibody.
MAEL expression is observed in fetal oocytes
throughout meiotic prophase I and in primordial
and primary follicles. Insets: MAEL single channel
(green) close-up views. Bars represent 10 mm.
(G) qRT-PCR analysis of L1 mRNA levels relative to
expression of germ cell-specific Mvh. Mean ± SD
from three independent measurements are shown,
t = 10.82, p = 0.0004.
(H) Western blot detection of L1ORF1p relative to
TRA98 expression in E15.5 ovaries based on re-
sults of analysis of three biological replicates.
Dashed line marks the cut line of the membrane.
(I) Quantification of western blot data shown in (H).
Mean ± SD from three independent measurements
are shown, t = 9.31, p = 0.0007.
Two-tailed unpaired Student’s t test, ***p < 0.001
(G and I). See also Figure S2 and Table S1.
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oocyte populations were distinct from their respective WT
counterparts and contained more oocytes with higher nuclear
L1ORF1p levels (Tables S2C and S2D). By P2, however, the
maximum nuclear L1ORF1p level in WT oocytes (40% of the
starting E15.5 population) decreased to 3.13 RMN units. In
contrast, L1ORF1p levels remained high in viable Mael-null P2
oocytes (14% of the starting E15.5 population). These results
established that WT and Mael-mutant fetal and early postnatal
ovaries contained highly heterogeneous populations of MPI
oocytes characterized by differential and dynamic accumulation
of L1ORF1p in their nuclei.
The unexpected variation of L1ORF1p levels as early as E15.5
could arise from any combination of differential DNA demethyla-
tion and derepression of 11,000 full-length L1 elements in the
mouse genome (Goodier et al., 2001) or asynchronous onset of
epigenetic reprogramming. To reconcile oocyte viability data
with differential L1ORF1p nuclear accumulation in both geno-
types, we hypothesized that the developmental fate of a fetal
oocyte (survival versus elimination) could be determined by its
nuclear L1 content. This idea is based on prior evidence of
increased DNA damage and meiotic defects following L1 activa-
tion (Belgnaoui et al., 2006; Gasior et al., 2006; Soper et al., 2008)
and increased L1 expression and FOA in the absence of Mael
(Figures 2G–2I and 3A). A simplest scenario was that L1ORF1p
nuclear levels (hence L1 activity) in an E15.5 oocyte determine
the probability of its survival to E18.5 or P2. To test this model,
we ranked E15.5 oocytes of both genotypes (representing start-Developmental Cell 29, 521–ing oocyte populations) according to their
RMN L1ORF1p values and intersected
percent survival of E15.5 oocytes to
E18.5 and P2 with corresponding RMN
L1ORF1p curves (Figures 3E and 3F).This operation identified close maximum RMN values for WT
and Mael-null oocytes corresponding to their survival to E18.5
(1.62 and 1.49 RMN units, respectively) and P2 (1.42 and 1.35
RMN units, respectively). This analysis suggested that WT
and Mael-null E15.5 oocytes with L1ORF1p levels above the
threshold of 1.6 RMN units were first to accumulate lethal levels
of L1 activity before E18.5, whereas E15.5 oocytes with RMN
L1ORF1p values from 1.35 to 1.6 units survived past E18.5 but
were killed by P2. This analysis strongly supported our working
hypothesis that L1 could play a role in FOA by causing elimina-
tion of oocytes with excessive L1 activity. Furthermore, in agree-
ment with prior studies of L1 derepression on meiotic cells, this
analysis predicted the appearance of nonmeiotic DNA double-
stranded breaks (DSBs) in WT fetal oocytes and increased
incidence of meiotic defects in Mael-null fetal oocytes overex-
pressing L1.
Nonmeiotic DNA Double-Stranded Breaks in WT Fetal
Oocytes
We have previously shown that derepression of L1 elements is
accompanied by the appearance of SPO11-independent, non-
meiotic DSBs (Romanienko and Camerini-Otero, 2000; Soper
et al., 2008). By analogywith spermatocytes lacking L1 silencing,
our observations made in fetal oocytes led us to test the predic-
tion that Spo11-null but otherwise WT fetal oocytes should
possess nonmeiotic DSBs. Indeed, antibodies to RAD51 recom-
binase, a RecA homolog, revealed that 38% of E16.5 Spo11-null
oocytes contained RAD51 foci indicative of nonmeiotic DSBs533, June 9, 2014 ª2014 Elsevier Inc. 523
Figure 3. Viability of Wild-Type and Mael-Null Oocytes Correlates with Nuclear L1ORF1p Levels
(A) Quantification of WT and Mael-null oocytes. Mean ± SD from at least three independent measurements are shown (two-tailed unpaired Student’s t test;
ns, p > 0.05; ***p < 0.001).
(B) Variable (low and high) nuclear L1ORF1p levels (green) in E15.5 WT oocytes. SYCP2 (red) marks the synaptonemal complex.
(C) Representation of three-dimensional reconstruction from single confocal sections, and generation of the nuclear surface (cyan) within which green signal
intensity is quantified to determine L1ORF1p RMN levels in oocyte nuclei using Imaris Software.
(D) Dot-plot of RMN L1ORF1p levels in WT and Mael-null oocytes (two-tailed Kolmogorov-Smirnov test; ***p < 0.001).
(E) E15.5 WT and Mael-null oocytes ranked according to their RMN L1ORF1p levels.
(F) Chart relating RMNL1ORF1p levels inWT andMael-null E15.5 oocytes to percentage of their survival to E18.5 and P2. Boxed area in (E) is shown in detail in (F).
See also Table S2.
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positive oocytes (32% of all oocytes scored) possessed fewer
than nine RAD51 foci whereas 6% of oocytes contained
numerous DSBs (Figure 4B). The presence of Spo11-indepen-
dent DNA breaks in fetal oocytes, independently observed by
others (Carofiglio et al., 2013), strongly supports our working
hypothesis of a role for L1 elements in FOA.
DNA Damage and Asynapsis in Mael-Null Oocytes
We next assessed the impact of the Mael deletion (hence asso-
ciated L1 overexpression) on MPI. We first compared the distri-
bution of MPI substages in WT and Mael-null E18.5 ovaries and
concluded that theMaelmutation did not alter the progression of
MPI (Figure S3A and Table S3). Labeling of nuclear spreads of
E18.5 pachytene oocytes for gH2AX, a marker of DSBs and
unpaired meiotic chromatin, (Turner et al., 2005) identified that
42.8% of Mael-null oocytes harbored such defects compared
to 16.8% in the WT (Figure 4C and Table S4A). Antibodies
to RAD51 revealed unrepaired DSBs in 35.6% of Mael-null524 Developmental Cell 29, 521–533, June 9, 2014 ª2014 Elsevier Incompared to 12.8% of WT oocytes (Figure 4C and Table S4A).
Costaining for synaptonemal complex markers SYCP1 and
SYCP2 revealed incomplete homologous chromosome synapsis
in 37.4% of Mael-null E18.5 oocytes compared to 8.3% of WT
(Yang and Wang, 2009; Figure 4C and Table S4A). We also
labeled fetal oocytes for BRCA1, a component of the synapsis
quality control mechanism known as meiotic silencing of un-
paired chromatin (MSUC; Ichijima et al., 2011; Mahadevaiah
et al., 2008; Schimenti, 2005; Turner, 2007; Turner et al., 2004,
2005). This analysis allows positive identification of even small
areas of chromosome asynapsis but is limited to oocytes with
asynapsis of fewer than two or three homologous chromosomes
(Kouznetsova et al., 2009). This analysis revealed MSUC in
18.2% of WT E18.5 oocytes, suggesting the presence of small
areas of asynapsis that could not be reliably identified with
SYCP1/SYCP2 costaining (Figures 4C and S3C–S3F; Table
S4A). In the Mael mutant, BRCA1 antibody labeled 32.4% of
E18.5 oocytes that when compared to SYCP1/SYCP2 staining
suggested a higher extent of asynapsis in the presence ofc.
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Overall, this analysis demonstrated that up to 18% of WT and
40% of Mael-null E18.5 oocytes possessed clear evidence of
meiotic defects including unrepaired DSBs and asynapsis,
known as primary triggers for oocyte elimination during the peri-
natal and early postnatal period (Di Giacomo et al., 2005).
Consistent with DNA damage- and asynapsis-activated
oocyte loss during the perinatal period, the number of primordial
follicles was severely reduced in P19Mael-null ovaries (Figure 4D
and Table S4B; Di Giacomo et al., 2005). Furthermore, we did not
observe signs of folliculogenesis in ovaries of 1-year-old mice
(Figure 4E). Thus, increased L1 expression in Mael-mutant fetal
oocytes is associated with extensive DNA damage, MPI defects,
a severely reduced ovarian follicle reserve, and shortened female
reproductive lifespan.
Crossover and Meiotic Chromosome Segregation
Defects in Mael-Null Oocytes
A crucial outcome of MPI is the formation of crossovers that are
essential for the precise meiotic chromosome segregation. To
assess the effect of theMaelmutation and associated increased
L1 expression on crossover formation, we examined the locali-
zation of mismatch repair protein MLH1 normally recruited to
one to three foci on each synaptonemal complex (Baker et al.,
1996). Unexpectedly, we found that 97% of allMael-null pachy-
tene E18.5 oocytes with fully synapsed homologous chromo-
somes were lacking MLH1 foci on at least one chromosome
bivalent (Figures 5A, 5D, and S4A–S4C; Tables S4A, S4C, and
S4D). This defect could not be attributed to reduced Mlh1
mRNA and protein levels (Figures S4E–S4G). Consistent with
this finding, 70% of metaphase I Mael-null oocytes possessed
univalent chromosomes (Figures 5B and 5D; Table S4A) whereas
the remaining 30%mutant oocytes exhibited a significant reduc-
tion of the average number of chiasmata per oocyte (20.9 ± 1.7
compared to 23.4 ± 1.5 in the WT; Table S4C). Among ovulated
metaphase II Mael-null oocytes, 60% had abnormal karyotypes
(Figures 5C and 5D; Table S4A) and their fertilization with WT
sperm resulted in 52.5% embryonic aneuploidy at the two-cell
stage (Figures 5E and 5F; Table S5A) and 57% lethality before
the blastocyst stage (Figure 5G and Table S5B). These observa-
tions suggest that elevated L1 expression might interfere with
crossover formation leading to meiotic chromosome segrega-
tion errors in the adult ovary.
Conditional Expression of an L1 Element ORFeus
Enhances Fetal Oocyte Attrition and Meiotic Defects
We next asked ifMaelmutant phenotypes could be reproduced
by directly increasing L1 expression in fetal oocytes. To substan-
tially increase L1 expression over an already high background
level of expression of as many as 11,000 full-length endogenous
L1 elements in the mouse genome (Goodier et al., 2001;
Figure 1B), we used a recently described mouse transgene car-
rying a tetracycline-controlled L1 element (ORFeus; Figure 6A;
O’Donnell et al., 2013). Consistent with our earlier results, doxy-
cycline-induced CMV-rtTA/+; tet-ORFeus/+ (FVBB6F1) fetal
ovaries contained 14 and 13 percentage points fewer oocytes
at E18.5 and P2, respectively, compared to the control group
comprising nondouble transgenic littermates (Figure 6B, Tables
S6A–S6C, and Experimental Procedures). Quantification ofDeveL1ORF1p revealed the appearance of E15.5 CMV-rtTA/+; tet-
ORFeus/+ oocytes with increased nuclear levels of the protein
that peaked at E18.5 but become depleted by P2 (Figure 6C;
Tables S6D and S6E). Despite a potentially slight delay in the
onset of ORFeus expression, RMN L1ORF1p values in the
E15.5 control and double transgenic populations were nonethe-
less significantly distinct to reveal a correlation between the
survival of E15.5 oocytes to E18.5 and P2 with their nuclear
L1ORF1p levels (Figures 6D and 6E).
To assess the effect of ORFeus overexpression on MPI, we
first compared the distribution of MPI substages in doxycy-
cline-induced control and CMV-rtTA/+; tet-ORFeus/+ E18.5
ovaries and determined that ORFeus overexpression did not
alter the MPI progression (Figure S3B). We next examined both
groups of E18.5 oocytes for the presence of MPI defects.
Consistent with prior results of others (Koehler et al., 2006), we
observed an increased baseline level of meiotic defects in
oocytes of mixed genetic background. Nevertheless, doxycy-
cline-induced E18.5 CMV-rtTA/+; tet-ORFeus/+ oocytes still
accumulated RMN L1ORF1p levels sufficient to further increase
DNA damage and chromosome asynapsis in oocytes surviving
to E18.5 (Figure 6F and Table S6F). Subsequent labeling of
E18.5 CMV-rtTA/+; tet-ORFeus/+ oocytes for BRCA1 suggested
that ORFeus overexpression caused extensive chromosome
asynapsis as indicated by a lower percent of MSUC-positive
oocytes (9.4%) compared to 19% of asynapsed oocytes as
determined by SYCP2 staining (Figure 6F and Table S6F). At
the same time, ORFeus overexpression did not cause a statisti-
cally significant increase of oocytes lackingMLH1 foci on at least
one chromosome bivalent (Figure 6F; Tables S6F and S6G).
Perhaps the mechanism underlying the inhibitory effect of L1
on MLH1 localization to prospective crossover sites requires
stronger L1 expression than offered by a single ORFeus trans-
gene. Nonetheless, considered as a whole, the analysis showed
that direct overexpression of a single L1 element in the fetal
ovary had substantially enhanced oocyte elimination and rein-
forced the idea that L1 activity contributes to FOA.
Reverse Transcriptase Inhibitor AZT Alters Dynamics of
Fetal Oocyte Attrition
To test the key prediction of our working hypothesis that inhibi-
tion of L1 activity should reduce FOA, we gave pregnant female
mice azidothymidine (AZT), a nucleoside analog inhibitor of
reverse transcriptases (RTs) including L1ORF2p that has inde-
pendent RT and endonuclease activities (Dai et al., 2011; Feng
et al., 1996; Jones et al., 2008; Figure 7A). We first determined
that AZT treatment did not perturb MPI progression or induce
oocyte proliferation (Figures S3A and S5). Quantification of the
oocyte content of AZT-treated WT and Mael-null ovaries re-
vealed a profound yet complex effect of the drug on oocyte
viability (Figure 7B; Tables S7A–S7C). In contrast to untreated
controls, AZT-treated WT E18.5 ovaries retained practically an
entire starting oocyte population (96%). Likewise, 61% of the
starting oocyte population survived in the AZT-treated E18.5
Mael-mutant ovaries. The effect of AZT on E18.5 oocyte survival
was sufficiently robust to be apparent in whole-mount oocyte
staining of WT and Mael-null E18.5 ovaries (Figure 7C). This
result strongly supported the idea of a role of L1 in FOA and sug-
gested that an RT-dependent intermediate or step during L1lopmental Cell 29, 521–533, June 9, 2014 ª2014 Elsevier Inc. 525
Figure 4. Nonmeiotic DSBs and Meiotic Prophase I Defects in Fetal Oocytes
(A) A three-dimensional image of a section of a WT and Spo11-null E16.5 ovary immunostained for RAD51 (green) and SYCP2 (red).
(B) Quantification of RAD51 foci in Spo11-null E16.5 oocytes.
(legend continued on next page)
Developmental Cell
L1 in Fetal Oocyte Attrition
526 Developmental Cell 29, 521–533, June 9, 2014 ª2014 Elsevier Inc.
Figure 5. Crossover Defects, Aneuploidy,
and Premature Ovarian Oocyte Depletion
in the Mael-Null Mutant
(A) Representative images and quantification of
prospective crossovers identified using MLH1
antibody (green) in WT and Mael-null E18.5
pachytene nuclei. Insets: close-up views of syn-
aptonemal complexes (identified with asterisks)
with two and none MLH1 foci.
(B and C) Representative images and quantifica-
tion of karyotypes inmetaphase I andmetaphase II
WT and Mael-null oocytes. Arrow in defective MI
oocyte (B) identifies one of 30 chromosomal uni-
valents present in this sample. Arrow in defective
MII oocyte (C) identifies a single extra chromo-
some.
(D) Quantification of defective oocytes in (A–C).
(E) Quantification of aneuploid karyotypes of two-
cell embryos obtained from Mael-null and control
WT oocytes.
(F) Representative image of an aneuploid karyo-
type (43 chromosomes) of an E1.5 Mael+/
embryo.
(G) Staging of Mael+/ embryos developed from
Mael-null oocytes and control WT embryos
collected at E3.5 1C, 1-cell; 2C, 2-cell; 3–8C, 3-
to 8-cell arrested embryos; M, morula; and B,
blastocyst.
Two-tailed Fisher’s exact test; ns, p > 0.05; **p <
0.01; ***p < 0.001 (D, E, and I). See also Figure S4
and Tables S4 and S5.
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(E15.5–E18.5), before the engagement of checkpoints moni-
toring the completion of meiotic DNA recombination and synap-
sis starting at E18.5.
Quantification of L1ORF1p immunofluorescence in AZT-
treated WT and Mael-null E18.5 oocytes revealed the presence
of predicted but previously undetected oocytes with L1ORF1p
levels greatly exceeding those observed in untreated ovaries
(Figure 7D; Tables S7D–S7F). L1ORF1p nuclear levels peaked
at 20.7 and 36.8 RMN units in AZT-treated WT and Mael-null
E18.5 oocytes, respectively. Because practically all AZT-treated
WT oocytes survived to E18.5, L1ORF1p nuclear accumulation(C) Representative images of pachytene meiotic spreads and quantification of defective patterns of DNA dam
respectively with gH2AX, RAD51, SYCP1, and BRCA1 antibodies (green). SYCP2 (red) marks synaptonem
abnormal patterns indicated with asterisks. Two-tailed Fisher’s exact test; *p < 0.05; ***p < 0.001.
(D) Follicle counts in P19WT andMael/ ovaries. Lack of primordial follicles is apparent in P19Maelmutant o
number of primary and pre-antral follicles. Mean ± SD from at least three independent biological measuremen
ns, p > 0.05; **p < 0.01).
(E) Hematoxylin and eosin-stained sections of ovaries of 1-year-old WT and Mael/ females.
See also Figure S3 and Tables S3 and S4.
Developmental Cell 29, 521–in WT fetal oocytes has a maximum of
about 20 RMN units. In light of these
data and an up to 2.4-fold increase in L1
expression levels in the Mael-null ovaries
(Figures 2D–2I), AZT-treated Mael-null
oocytes should have peaked at 46 RMN
units but in reality did not exceed the
maximum of 36.8 RMN units. Most likely,
the concentration of AZT used in our ex-periments (5 mg/kg/day) was insufficient to block RT in Mael-
null oocytes with most L1 expression resulting in elimination of
39% of the starting oocyte population. Taken together, these
observations support the idea of preferential elimination of fetal
oocytes with excessive levels of nuclear L1ORF1p during FOA.
Despite the strong protective effect of AZT on early (E15.5–
E18.5) MPI oocytes, we found that AZT-treated WT and Mael-
mutant P2 ovaries contained 41%and 31%of the starting oocyte
populations, respectively. A sharpdrop in oocyte viabilitywas not
unexpected because AZT does not inhibit the endonuclease ac-
tivity of L1ORF2p. Up to 40% of AZT-treated WT E18.5 oocytes
exhibited MPI defects, which is consistent with the percent ofage, DNA repair, synapsis, and MSUC, assessed
al complex lateral elements. Insets: close-ups of
varies. No effect ofMael deletion is observed on the
ts are shown (two-tailed unpaired Student’s t test;
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Figure 6. Effects of Doxycycline-Inducible tet-ORFeus Expression on Fetal Oocytes
(A) Diagram of experimental induction of tet-ORFeus expression.
(B) Quantification of oocytes in doxycycline-induced nondouble transgenic control and CMV-rtTA/+; tet-ORFeus/+ embryos. Mean ± SD from at least three
independent biological measurements are shown (two-tailed unpaired Student’s t test; ns, p > 0.05; *p < 0.05; ***p < 0.001).
(C) Dot-plot of RMN L1ORF1p levels in nondouble transgenic control and CMV-rtTA/+; tet-ORFeus/+ doxycycline-induced oocytes. Each dot represents the
RMN level in an individual oocyte nucleus. Two-tailed Kolmogorov-Smirnov test; *p < 0.05; **p < 0.01; ***p < 0.001.
(D) E15.5 nondouble transgenic control and CMV-rtTA/+; tet-ORFeus/+ oocytes ranked according to their RMN L1ORF1p levels. Boxed area is shown in
detail in (E).
(E) Chart relating RMN L1ORF1p levels in nondouble transgenic control and CMV-rtTA/+; tet-ORFeus/+ E15.5 oocytes to percentage of their survival to E18.5
and P2.
(F) Quantification of E18.5 nondouble transgenic control and CMV-rtTA/+; tet-ORFeus/+ doxycycline-induced oocytes exhibiting evidence of DNA damage and
MSUC (gH2AX staining), persistent DSBs (RAD51 foci), asynapsis (abnormal SYCP2 staining), MSUC (BRCA1 staining), and lacking MLH1 foci. Two-tailed
Fisher’s exact test; ns, p > 0.05; *p < 0.05; **p < 0.01.
See also Figure S3 and Tables S3 and S6.
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L1 in Fetal Oocyte Attritioneliminated E18.5 oocytes in untreated WT ovaries (Figure 7E;
Tables S7G and S7H). Likewise, in addition to 39% of Mael-null
oocytes eliminated by E18.5, up to 37% of AZT-treated E18.5
oocytes possessed elevatedDNAdamage and asynapsis. These
defects were the likely triggers of checkpoint activation and a
sharp decline in oocyte numbers in the early postnatal period
(Figure 7B; Tables S7A and S7B; Di Giacomo et al., 2005).
Finally, we examined the effect of AZT treatment on the num-
ber and distribution of MLH1 foci. In stark contrast to untreated
Mael-null E18.5 oocytes, 97% of which lacked MLH1 foci on at
least one chromosome bivalent, we found that only 28.9% of
AZT-treated Mael-null E18.5 oocytes exhibited such a defect
(Figure 7E; Tables S7G–S7J). The mean number of MLH1 foci
in Mael-null E18.5 oocytes increased from 9.97 ± 5.32 without528 Developmental Cell 29, 521–533, June 9, 2014 ª2014 Elsevier Intreatment to 22.76 ± 6.24 in the presence of AZT (Figure S5
and Table S7I). Furthermore, quantification of MLH1 foci in
AZT-treated E18.5WT oocytes revealed a statistically significant
increase in the mean number of MLH1 foci from 26.55 ± 5.94 to
28.83 ± 4.9 (Figure S5; Tables S7I and S7J). These findings sug-
gest that an RT-dependent intermediate of L1 retrotransposition
interferes with crossover formation not only in the absence of
Mael, but also under basal conditions of L1 expression in WT
MPI oocytes.
Considered as a whole, the results of analysis of WT andMael-
mutant ovaries treated with AZT are highly consistent with the
hypothesis that L1 activity plays a role in FOA and suggest that
intermediates of L1 retrotransposition such as L1 RNA-DNA
hybrids might trigger elimination of early MPI oocytes.c.
Figure 7. Fetal Oocyte Attrition and Meiotic Prophase I Progression in AZT-Treated Mice
(A) Diagram of AZT treatment of pregnant WT and Mael+/ mutant females.
(B) Quantification of untreated and AZT-treated WT and Mael-null oocytes. Mean ± SD from at least three independent measurements are shown (two-tailed
unpaired Student’s t test; ns, p > 0.05; ***p < 0.001; **p < 0.01, *p < 0.05).
(C) Whole-mount TRA98 (green) labeling of fetal oocytes in untreated and AZT-treated WT and Mael-null ovaries.
(D) Dot-plot of RMN L1ORF1p levels in AZT-treated WT and Mael-null oocytes (two-tailed Kolmogorov-Smirnov test; ns, p > 0.05; ***p < 0.001).
(E) Quantification of untreated and AZT-treated WT and Mael-null E18.5 oocytes exhibiting evidence of DNA damage and MSUC (gH2AX staining), persistent
DSBs (RAD51 foci), asynapsis (abnormal SYCP2 staining), MSUC (BRCA1 staining), and lacking MLH1 foci. Two-tailed Fisher’s exact test; ns, p > 0.05; ***p <
0.001; **p < 0.01; *p < 0.05.
See also Figures S3 and S5 and Tables S3 and S7.
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In this work, we examined a role of retrotransposon L1 in FOA in
mice. We reasoned that expression of L1 elements following
their activation in the course of epigenetic reprogramming couldDevebe detrimental to viability of MPI fetal oocytes. We have uncov-
ered differential accumulation of nuclear L1ORF1p, hence
L1RNPs, among WT fetal oocytes. By studying fetal oocytes of
WT and L1-overexpressing mice, we established a correlation
between fetal oocyte nuclear L1ORF1p levels and oocytelopmental Cell 29, 521–533, June 9, 2014 ª2014 Elsevier Inc. 529
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L1 in Fetal Oocyte Attritionviability. We used two different strategies to increase L1 expres-
sion in fetal oocytes to assess if high levels of L1 associate with
enhanced MPI defects and oocyte elimination. A null mutation in
the Mael gene allowed an up to 2.4-fold increase in global L1
expression that resulted in a 3-fold reduction in the number of
fetal oocytes at birth. Induction of expression of a single L1
elementORFeus at the onset of MPI has also resulted in reduced
oocyte survival that can be correlated with nuclear L1ORF1p
levels. Whereas not as strong as the Mael mutant phenotype,
the effect of ORFeus overexpression is quite significant espe-
cially in light of the fact that the mouse genome is estimated to
encode 11,000 full-length L1 elements (Goodier et al., 2001). A
central role of L1 in FOA is also strongly supported by results
of experiments using RT inhibitor AZT, the administration of
which had an immediate positive effect on the dynamics of
FOA in WT and Mael mutant ovaries. Furthermore, AZT treat-
ment caused a 3-fold increase in the number of Mael-null
oocytes with normal localization of MLH1 protein to prospective
crossover sites. Overall, our data support the ‘‘death by defect’’
model of FOA (Tilly, 2001) with both reverse transcriptase and
endonuclease activities of L1ORF2p contributing to oocyte elim-
ination. AZT-dependent protection of oocytes during early MPI
(E15.5–E18.5) suggests that L1 RNA-DNA hybrids, formed in
the process of target-primed retrotransposition of L1 elements,
could trigger FOA. This unexpected finding and the presence
of nonmeiotic DSBs agree with an earlier observation that both
domains of L1ORF2p contributed individually to cytotoxicity of
expression of human L1 element in HeLa cells (Wallace et al.,
2008).
Our work has yielded two additional significant findings. First,
we observed differential nuclear accumulation of L1ORF1p
among otherwise genetically identical oocytes, including WT.
The mechanism behind this observation remains to be eluci-
dated. Perhaps the onset or extent of DNA demethylation of
the mouse genome varies between individual primordial germ
cells and MPI oocytes leading to differential expression of L1
elements (Kagiwada et al., 2013; Ohno et al., 2013). L1 mobili-
zation during early embryogenesis might also lead to a greater
diversity of genotypes than had been anticipated previously
(Kano et al., 2009). Second, our data suggest that L1 activity
in fetal oocytes might contribute to meiotic chromosome
segregation errors in the adult ovary. The mechanism of this
phenomenon is not yet clear but the rescue of the MLH1 local-
ization defect by AZT implicates newly synthesized L1 cDNA or
RNA-DNA intermediates in this process, perhaps by diverting
mismatch repair machinery from sites of prospective cross-
overs to numerous sites of L1 insertions spread throughout
the genome. This observation suggests that the maternal bias
of meiotic chromosome segregation errors might arise from
the concurrency of developmental timing of MPI and epigenetic
reprogramming in fetal oocytes. Considered together, our re-
sults lead us to conclude that L1 activity could be a potent
determinant of both the size and quality of a mammalian
ovarian oocyte reserve.
Finally, with respect to the rationale behind the massive loss
of oocytes, we propose that FOA selects oocytes with low L1
activity and, therefore, best suited for the next generation. In
the long run, limited exposure to L1might result in novel L1 inser-
tions and, therefore, negative effects of L1-driven oocyte demise530 Developmental Cell 29, 521–533, June 9, 2014 ª2014 Elsevier Inmight be balanced by positive effects of increased genetic
diversity.
EXPERIMENTAL PROCEDURES
Animals
ES cell targeting,Maelmutantmice derivation, backcross to C57BL/6J genetic
background for > 10 generations, and genotyping are described elsewhere
(Soper et al., 2008). Spo11 mutant mice were the gift of Dr. Camerini-Otero
(NIDDK; Romanienko and Camerini-Otero, 2000). Transgenic CMVrtTA/+
females in FVB genetic background (kindly provided by H.Varmus; Sotillo
et al., 2007) were mated with transgenic tet-ORFeus/+ males in C57BL/6J
genetic background (O’Donnell et al., 2013). All experimental procedures
were performed in compliance with ethical regulations and approved by the
IACUC of the Carnegie Institution for Science.
Oocyte and Follicle Counting
We scored all oocytes present in every fifth cryosection throughout the entire
ovary. To obtain an estimate of the total number of oocytes per ovary, the
numbers scored per sections were multiplied by 5 (Tilly, 2003). For statistical
analysis, we compared average number of oocytes per ovary counted in pairs
of ovaries coming from embryos from different litters as indicated in supple-
mental tables (Tables S2A, S2B, S6A–S6C, andS7A–S7C). To quantify follicles
in postnatal ovaries, we scored follicles as ‘‘primordial’’ if they contained an
intact oocyte with a visible nucleolus surrounded by a single layer of fusi-
form-shaped granulosa cells. We scored follicles as ‘‘primary’’ if they con-
sisted of an intact, enlarged oocyte with a visible nucleolus and a single layer
of cuboidal granulosa cells. We scored follicles as ‘‘preantral/antral’’ if they
contained an oocyte with a visible nucleolus and more than one layer of gran-
ulosa or thecal cells. For statistical analysis, we compared average number of
follicles per ovary counted in pairs of ovaries coming from females from
different litters as indicated in supplemental tables (Table S4B).
Induced ORFeus Expression
To induce tet-ORFeus expression, doxycycline hyclate (Sigma-Aldrich,
Cat#:D9891; 5 mg/ml in drinking water supplemented with 1% sucrose) was
provided ad libitum in opaque bottles to 2- to 6-month-old transgenic CMV-
rtTA/+ females mated with transgenic male tet-ORFeus/+ starting at
12.5 days postcoitum (dpc) and refreshed every 48 hr. Treated females were
dissected at 15.5 or 18.5 dpc, or P2 for subsequent analysis of ovaries. The
effect ofORFeus activation on oocyte fate was assessed by comparing embry-
onic ovaries from female double transgenic (CMV-rtTA/+; tet-ORFeus/+) with
their female littermates non-DOX-inducible nondouble transgenics (+/+; tet-
ORFeus/+), (CMV-rtTA/+; +/+), (+/+; +/+; O’Donnell et al., 2013). An indepen-
dent one-sample t test (Table S6C) demonstrates that the number of oocytes
did not differ between different nondouble transgenic littermates.
AZT Administration
To inhibit L1 reverse transcriptase in embryonic oocytes, pregnant 2- to
6-month-old Mael+/ females, mated with male Mael+/ males, received
5 mg/kg/day AZT (Sigma Aldrich, Cat#. A2169) by gavage starting at
12.5 dpc. Treated females were dissected at 15.5 or 18.5 dpc, or P2 for sub-
sequent analysis of oocytes. The route and doses of AZT used in this study
were based on previous reports (Dai et al., 2011; Sharpe et al., 1987, 1988;
Toltzis et al., 1991).
Analysis of L1ORF1p Nuclear Signal
We coimmunolabeled cryosections of embryonic ovaries for L1ORF1p and
germ cell marker (SYCP2 or TRA98), and counterstained with DAPI. We per-
formed confocal imaging using SP5 confocal microscope (Leica). The three-
dimensional reconstruction of generated Z-stacked images was performed
using Imaris Software (Bitplane). For each three-dimensional reconstructed
image, we determined the three-dimensional DAPI-rendered surfaces in indi-
vidual oocyte nuclei and collected mean intensity of green signals inside sur-
faces, corresponding to the mean intensity of nuclear oocyte L1ORF1p signal.
To eliminate the background signals, in parallel to oocyte nuclei analysis, on
each image we determine the three-dimensional DAPI-rendered surfaces ofc.
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collected mean intensity of green signals inside somatic cell nuclear surfaces.
For further analysis, we determined the relative mean nuclear (RMN) L1ORF1p
signals of oocytes for each image by normalizing nuclear mean intensity in
each examined oocyte to the average of nuclear mean intensity of L1ORF1p
signal of three ovarian somatic nuclei from the same image. We collected
RMN from at least 99 oocytes in different images of ovaries from at least three
different embryos for each embryonic stage and genotype.
RNA-Seq Analysis
We purified total RNA from E15.5 WT and Mael/ embryonic ovaries using
TRIzol (Invitrogen). We depleted total RNA samples from ribosomal RNA using
the Ribo-Zero rRNA Removal Kit (Epicenter) according to the manufacturer’s
instructions. rRNA removal was visually assessed by Agilent 2100 Bioanalyzer
(Agilent) RNA electropherograms. Library construction, cluster generation, and
sequencing on HiSeq 2000 (Illumina) were performed according to manufac-
turer’s protocols. We obtained a total of 8.2–8.9 3 107 filtered 100-base pair
reads for each ovarian sample. We used TopHat and Cufflinks to align reads
to mouse reference genome NCBI37/mm9 and to identify differentially ex-
pressed genes (Trapnell et al., 2009, 2010). To account for the relatively com-
plex cellular composition of the fetal ovary and anticipated variation in the
number of fetal oocytes between samples, we focused on two WT and two
mutant samples with best Pearson’s r correlation coefficients (Figure S2B).
Transcripts with ‘‘significant’’ Cuffdiff scores, FPKM count R 5, and a R2-
fold increase in expression in all four Mael mutant-WT pairwise comparisons
were considered reliably altered. By these criteria, only one gene (besides
Mael) was identified as downregulated (Table S1A) and 120 genes as upregu-
lated inMaelmutant ovaries compared toWT (Table S1B). By the same criteria,
no known germ cell or meiotic genes were found to be expressed differentially.
For analysis of expression of L1 elements belonging to young L1 families, we
aligned the reads to 2,383 intact, full-length L1 insertions in themouse genome
from the L1Base (http://l1base.molgen.mpg.de; Penzkofer et al., 2005; Zemoj-
tel et al., 2007). We used Bowtie software (Langmead et al., 2009) and allowed
for two mismatches. To account for the cellular complexity of WT and Mael
mutant ovaries analyzed and compared, we normalized count of mapped
reads to the level of expression of a germ cell marker, Mouse Vasa Homolo,
and a housekeeping gene Actin beta.
Gene Ontology Analysis
Gene ontology analysis of genes upregulated in Mael-null ovaries was done
using GOEAST software (Tables S1C and S1D; Zheng and Wang, 2008). GO
analysis is consistent with upregulation of apoptotic genes and contamination
with cells of the hematopoietic lineage.
Statistical Analysis
We performed all measurements independently at least in triplicate. We
analyzed random sample populations from at least three different samples
from three random animals. Sample size populations are indicated in the sup-
plemental tables. The genotyping to allocate animals to different experimental
groups were performed after sample processing. The random sample size
populations used in our analyses are representative of the entire population
with a 90%–95% confidence interval and 95% confidence level (Creative
Research Systems survey software, http://www.surveysystem.com/sscalc.
htm). Scoring of samples for analyses of meiotic prophase I progression was
performed with blinding genotypes. We assessed differences between quan-
titative variables for normal populations of small and large sizes with the two-
tailed unpaired Student’s t test (Figures 2G and 2I; Tables S2B, S4B–S4D,
S5A, S5B, S6B, S6C, S6G, S7B, S7C, S7I, and S7J) and with the one-sample
t test (Table S6C; QuickCalcs, http://www.graphpad.com/quickcalcs/index.
cfm); two-tailed Kolmogorov-Smirnov test for abnormal populations of large
size (Tables S2D, S6E, S7E, and S7F; http://www.physics.csbsju.edu). We
assessed qualitative variables with two-tailed Fisher’s exact test of popula-
tions of small and large sizes (Tables S4A, S5B, S6F, S7G, and S7H) and
chi-square test (Table S3B; QuickCalcs). Throughout the report, statistical sig-
nificance is indicated as (*) for p < 0.05, (**) for p < 0.01, (***) for p < 0.001, and
(ns) for p > 0.05.
Details of the other standard methods and reagents are described in the
Supplemental Experimental Procedures.DeveACCESSION NUMBERS
The NCBI Short Read Archive accession number for the high-throughput
sequencing data is SRP040979.
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